EDGAR Filing Documents for 0001564590-17-025058

Form 8-K - Current report:

SEC Accession No. 0001564590-17-025058

Filing Date

2017-12-18

Accepted

2017-12-18 17:22:22

Documents

Period of Report

2017-12-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	xene-8k_20171218.htm	8-K	39493
2	EX-4.1	xene-ex41_23.htm	EX-4.1	139681
3	EX-10.1	xene-ex101_24.htm	EX-10.1	412929
	Complete submission text file	0001564590-17-025058.txt		593394

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W

Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300

Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)